Stay updated on Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added the keyword/MeSH term 'B-cell chronic lymphocytic leukemia.' Added a new resource link to the Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-04-02T15:27:15.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision tag updated to v3.5.0, replacing v3.4.3. This is a UI/version change and does not alter study details or eligibility.
    Difference
    0.1%
    Check dated 2026-03-19T03:29:05.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T20:12:47.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Updates to the study record dates show new entries on 2026-03-02, 2026-02-26, and 2026-02 and removal of entries on 2025-12-24, 2025-12-08, and 2025-12, indicating revisions to the trial information.
    Difference
    0.2%
    Check dated 2026-03-04T15:16:18.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Footer and navigation updates removed references to the Moffitt Cancer Center Clinical Trials website and the H. Lee Moffitt Cancer Center and Research Institute. A new Revision: v3.4.2 tag was added.
    Difference
    0.6%
    Check dated 2026-02-11T05:50:38.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    A government funding notice was added and the revision stamp updated to v3.4.1 (replacing the previous v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T05:46:07.000Z thumbnail image

Stay in the know with updates to Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial page.